JENNIFER SMITH: Open Payments
NPI 1497270268 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,761 in 99 payments from 14 companies in 2025. Trend: 2023 $1,603 · 2024 $1,631 · 2025 $1,761
Food & beverage: $1,742Education: $19
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 38 | $633 |
| ABBVIE INC. | 29 | $386 |
| UCB, Inc. | 6 | $179 |
| Lilly USA, LLC | 5 | $133 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| Amgen Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Organon LLC | 3 | $30 |
| Galderma Laboratories, L.P. | 1 | $25 |
Products named: TREMFYA, SKYRIZI, Bimzelx, TALTZ, Otezla, DUPIXENT, LIBTAYO, COSENTYX.
Industry payments across OR — which companies pay providers there.
